Scientific & Economic Challenges in Early Drug Development
May 06, 2010 – May 11, 201012:00 pm - 4:30 pm
Agenda
Identification and mitigation of risks in First-In-Human clinical trials - pitfalls and challenges
Dr. John Lambert, Vice President and Chief Medical Officer, Early Phase
Accelerating Early Phase FIH to PoC - focus on CNS
Dr. Larry Ereshefsky, Vice President and Principal Consultant, Early Phase
Non-clinical and regulator strategies to support early clinical drug development
Dr. David Morse, Principal Consultant/Director, Early Phase Strategic Services
Dates & Locations
Thursday, May 6: Boston, Massachusetts
Friday, May 7: Bridgewater, New Jersey
Monday, May 10: San Francisco, California
Tuesday, May 11: San Diego, California
Registration
This event is complimentary for members of the biopharmaceutical industry. Please e-mail Martina Docherty at martina.docherty@parexel.com for registration or further details.
PAREXEL Speakers Bureau
PAREXEL is your reliable source for knowledgeable speakers on issues affecting the pharmaceutical, biological, and medical device industries.
In addition to being leading subject matter experts, members of the PAREXEL team are experienced at delivering lively and compelling presentations to a broad range of audiences. If you need a speaker for an upcoming event, please click here.